drugset / Trial / NCT00250172

PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram

NCT00250172

Phase 1 Completed 26 enrolled National Institute of Mental Health (NIMH)
Treatment

Summary

The purpose of this study is to measure a particular protein in the brain called the phosphodiesterase by using the imaging techniques of positron emission tomography (PET) and magnetic resonance imaging (MRI). ...

Timeline

Start
2005-10-31
Primary completion
2009-02-05
Completion
2009-02-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rolipram Diagnostic / imaging agent

Indications

No indication recorded.